-+ 0.00%
-+ 0.00%
-+ 0.00%

Predictive Oncology Q3 EPS $(107.25), Sales $3.618K Down From $3.907K YoY

Benzinga·11/14/2025 22:23:48
Listen to the news
Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(107.25) per share which missed the analyst consensus estimate of $(1.35) by 7844.44 percent. This is a 1377.27 percent decrease over losses of $(7.26) per share from the same period last year. The company reported $3.618 thousand in sales this quarter. This is a 7.40 percent decrease over sales of $3.907 thousand the same period last year.